EUVIMED · CrossrefZeitschrift
Precision Medicine and Engineering
ISSN 2950-4821 · Elsevier BV
Neueste Artikel
Synthetic Bioactive Peptides for Skin Diseases: From Rational Design to Therapeutic Applications
The SLC7A11/GSH/GPX4 Axis as a Promising Therapeutic Target for Inducing Regulated Cell Death in Cancer
Injectable biomedical hydrogels: In situ construction and service stability
Nanodrug delivery systems for targeted treatment of inflammatory bowel disease
Artificial cells in disease therapy: Structural and functional biomimicry, challenges, and future perspectives
Crossing biological barriers: recent advances in nanotechnology for cytosolic protein drug delivery systems
CRISPR delivery systems for organ-specific targeting: Advances and challenges
Nanozymes as emerging catalytic therapeutics for the intervention of metabolic diseases
Nanodrug delivery system for precision treatment of pulmonary fibrosis
MXene-based functional nanomaterials and their applications in cancer diagnosis and therapy
Extracellular vesicles as precision therapeutic Vectors: Charting the future of cell-targeted Therapies
Natural polysaccharide-based hydrogels for hemostasis and wound healing: A review
Advances in engineered bacteria for cancer therapy
Microbially synthesized nanomaterials: Advances and applications in biomedicine
The role of nanoparticle mechanical properties in drug delivery and cancer therapy
Precise CAR-T cell therapy targeting non-cancerous diseases: Advances in precision medicine and bioengineering
Chitosan hydrogels loaded with pH-responsive nanozymes for precision treatment of wound infection
Stimulus-responsive polysaccharide-based hydrogels: From design to biomedical applications
Precision medicine and engineering: Advancing Personalized Healthcare
Tumor-targeting drug delivery regimens based on vascular disrupting agents
Polymer vesicles as nanoreactors for biomedical applications
High extracellular matrix stiffness promotes the metastasis of nasopharyngeal carcinoma through STAT3/FGF1 positive feedback regulation activated by JAK2
Intratumor heterogeneity in breast cancer: Tracing its origins and translating findings into clinical practice
Phosphatidylserine-binding molecules induce the formation of tumor cell-derived microvesicles for enhanced cancer immunotherapy
Research on enzymatic co-assembly nanomedicine in oral squamous cell carcinoma
Overcoming biological barriers: Precision engineered extracellular vesicles for personalized neuromedicine
The hope of engineered T cells to cure diseases of the central nervous system
Investigating coacervates as drug carriers using molecular dynamics
Bacteria-based bioactive materials for tumor immunotherapy
Radiolabelled nanomaterials for diagnostic and therapeutic applications in hepatocellular carcinoma and other liver diseases
EUVIMED